Syngene Intl. (SYNGENE)
STALWARTFairStock Score: 41/100 — MIXED
Score breakdown: P/E: 0/3 · ROCE: 1/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹428.35 |
| Market Cap | ₹17,012.1 Cr |
| P/E Ratio | 41.56 |
| ROCE | 13.52% |
| ROE | 7.45% |
| Dividend Yield | 0.3% |
| Profit Growth | -29.79% |
| Debt/Equity | 0.12 |
| Sales Growth | 5.05% |
| Free Cash Flow | ₹42,400 Cr |
| Promoter Holding | 52.68% |
| 52-Week Range | ₹380 — ₹728.6 |
| Sector | Healthcare Services |
| Book Value | ₹117.31 |
Syngene Intl. trades with a P/E ratio of 41.56, ROCE of 13.52%, ROE of 7.45%, profit growth of -29.79%, debt-to-equity of 0.12. The FairStock Score of 41/100 suggests mixed fundamentals — some metrics look solid while others need improvement.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer